Curis | CRIS - Текущие активы





Текущие активы Изменить Дата
Alaunos Therapeutics USD 1.99M 697K 2025-12
Amgen USD 31.48B 2.42B 2026-03
AstraZeneca USD 29.61B 890M 2026-03
Bayer EUR 32.91B 30M 2025-12
Bristol-Myers Squibb USD 27.21B 2.18B 2026-03
CSL USD 11.85B 1000K 2025-12
Curis USD 6.92M 7.5M 2025-12
Eli Lilly USD 54.84B 794M 2026-03
Exelixis USD 1.44B 41.03M 2025-12
Gilead Sciences USD 19.89B 1.05B 2025-12
GlaxoSmithKline GBP 17.76B 251M 2026-03
Incyte USD 5.48B 460.36M 2026-03
Merck USD 35.02B 8.5B 2026-03
Novartis USD 26.61B 3.85B 2026-03
Pfizer USD 42.82B 76M 2026-03
Roche Holding CHF 38.73B 3.03B 2025-12
Sanofi EUR 30.16B 789M 2026-03
Takeda JPY 3.12T 195.82B 2025-12
TG Therapeutics USD 630.76M 31M 2025-12
Verastem USD 223.41M 69.36M 2025-12
Xoma USD 110.71M 5.78M 2025-09